[CSPC] Cefixime Capsules, presented in a packaging of 0.1g per capsule, with 12 capsules per box, represent a potent pharmaceutical solution tailored for a wide spectrum of bacterial infections. This medication is formulated to target and effectively manage infections caused by sensitive strains such as Streptococcus (excluding Enterococcus), Streptococcus pneumoniaeisseria gonorrhoeae, Haemophilus catarrhalis, Escherichia coli, Klebsiella species, Serratia species, Proteus species, and Haemophilus influenzae.
Cefixime belongs to the third-generation cephalosporins, a class of antibiotics known for their broad-spectrum activity against Gram-negative and selected Gram-positive bacteria. It acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and eventual elimination of the pathogenic organism.
The recommended dosage regimen should be prescribed by a healthcare professional, account the patient's age, weight, renal function, and the severity of the infection. It is crucial to complete the entire course of treatment as directed, even if symptoms improve before the medication is exhausted. Compliance with the prescribed dosage is essential to prevent recurrence of infection and ensure eradication of the pathogenic bacteria.
Before initiating treatment with [CSPC] Cefixime Capsules, patients should inform their healthcare provider about any allergies to cephalosporins or other antibiotics, as well as medical conditions, particularly those affecting the kidneys or liver.
Though rare, more severe reactions can include:
Immediate medical attention should be sought if any occur.